Meta-analysis of TNF 308 G/A polymorphism and type 2 diabetes mellitus

PLoS ONE

Volumn 6, Issue 4, 2011, Pages

  Feng, Ren Nan ^a   Zhao, Chen ^a   Sun, Chang Hao ^a   Li, Ying ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ASIAN; CAUCASIAN; GENE; GENETIC ASSOCIATION; GENOTYPE; HUMAN; NON INSULIN DEPENDENT DIABETES MELLITUS; RISK ASSESSMENT; SENSITIVITY ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW; TNF GENE; VALIDITY; BIOLOGICAL MODEL; GENETIC PREDISPOSITION; GENETICS; META ANALYSIS; PUBLISHING; RISK FACTOR;

TNF PROTEIN, HUMAN; TUMOR NECROSIS FACTOR ALPHA;

DIABETES MELLITUS, TYPE 2; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MODELS, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PUBLICATION BIAS; RISK FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 79954547325     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0018480     Document Type: Article

References (37)

1. Wild S, Roglic G, Green A, Sicree R, King H, (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27: 1047-1053.
2. Hotamisligil GS, (2006) Inflammation and metabolic disorders. Nature 444: 860-867.
3. Dahlen E, Dawe K, Ohlsson L, Hedlund G, (1998) Dendritic cells and macrophages are the first and major producers of TNF-alpha in pancreatic islets in the nonobese diabetic mouse. J Immunol 160: 3585-3593.
4. Hotamisligil GS, Shargill NS, Spiegelman BM, (1993) Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259: 87-91.
5. Feng R, Li Y, Zhao D, Wang C, Niu Y, et al. (2009) Lack of association between TNF 238 G/A polymorphism and type 2 diabetes: a meta-analysis. Acta Diabetol.
6. Pociot F, Wilson AG, Nerup J, Duff GW, (1993) No independent association between a tumor necrosis factor-alpha promotor region polymorphism and insulin-dependent diabetes mellitus. Eur J Immunol 23: 3050-3053.
7. Wu X, Zhang WJ, Witt CS, Abraham LJ, Christiansen FT, et al. (1992) Haplospecific polymorphism between HLA B and tumor necrosis factor. Hum Immunol 33: 89-97.
8. Louis E, Franchimont D, Piron A, Gevaert Y, Schaaf-Lafontaine N, et al. (1998) Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clin Exp Immunol 113: 401-406.
9. Feng RN, Li Y, Sun CH, (2009) TNF 308 G/A polymorphism and type 1 diabetes: a meta-analysis. Diabetes Res Clin Pract 85: e4-7.
10. Boraska V, Rayner NW, Groves CJ, Frayling TM, Diakite M, et al. (2010) Large-scale association analysis of TNF/LTA gene region polymorphisms in type 2 diabetes. BMC Med Genet 11: 69.
11. Furuta M, Yano Y, Ito K, Gabazza EC, Katsuki A, et al. (2002) Relationship of the tumor necrosis factor-alpha -308 A/G promoter polymorphism with insulin sensitivity and abdominal fat distribution in Japanese patients with type 2 diabetes mellitus. Diabetes Res Clin Pract 56: 141-145.
12. Hamann A, Mantzoros C, Vidal-Puig A, Flier JS, (1995) Genetic variability in the TNF-alpha promoter is not associated with type II diabetes mellitus (NIDDM). Biochem Biophys Res Commun 211: 833-839.
13. Heijmans BT, Westendorp RG, Droog S, Kluft C, Knook DL, et al. (2002) Association of the tumour necrosis factor alpha -308G/A polymorphism with the risk of diabetes in an elderly population-based cohort. Genes Immun 3: 225-228.
14. Ishii T, Hirose H, Saito I, Nishikai K, Maruyama H, et al. (2000) Tumor necrosis factor alpha gene G-308A polymorphism, insulin resistance, and fasting plasma glucose in young, older, and diabetic Japanese men. Metabolism 49: 1616-1618.
15. Kim HR, Lee MK, Park AJ, (2006) [The -308 and -238 Polymorphisms of the TNF-alpha Promoter Gene in Type 2 Diabetes Mellitus.]. Korean J Lab Med 26: 58-63.
16. Ko GT, Lee SC, Pu YB, Ng MC, So WY, et al. (2003) Tumour necrosis factor-alpha promoter gene polymorphism at -308 (genotype AA) in Chinese subjects with Type 2 diabetes. Diabet Med 20: 167-168.
17. Li H, Groop L, Nilsson A, Weng J, Tuomi T, (2003) A combination of human leukocyte antigen DQB1*02 and the tumor necrosis factor alpha promoter G308A polymorphism predisposes to an insulin-deficient phenotype in patients with type 2 diabetes. J Clin Endocrinol Metab 88: 2767-2774.
18. Lindholm E, Bakhtadze E, Cilio C, Agardh E, Groop L, et al. (2008) Association between LTA, TNF and AGER polymorphisms and late diabetic complications. PLoS ONE 3: e2546.
19. Liu HL, Lin YG, Wu J, Sun H, Gong ZC, et al. (2008) Impact of genetic polymorphisms of leptin and TNF-alpha on rosiglitazone response in Chinese patients with type 2 diabetes. Eur J Clin Pharmacol 64: 663-671.
20. Morris AM, Heilbronn LK, Noakes M, Kind KL, Clifton PM, (2003) -308 Nco I polymorphism of tumour necrosis factor alpha in overweight Caucasians. Diabetes Res Clin Pract 62: 197-201.
21. Padovani JC, Pazin-Filho A, Simoes MV, Marin-Neto JA, Zago MA, et al. (2000) Gene polymorphisms in the TNF locus and the risk of myocardial infarction. Thromb Res 100: 263-269.
22. Santos MJ, Patino GA, Angel BB, Martinez HJ, Perez BF, et al. (2006) [Association between tumor necrosis factor-alpha promoter polymorphisms and type 2 diabetes and obesity in Chilean elderly women]. Rev Med Chil 134: 1099-1106.
23. Shiau MY, Wu CY, Huang CN, Hu SW, Lin SJ, et al. (2003) TNF-alpha polymorphisms and type 2 diabetes mellitus in Taiwanese patients. Tissue Antigens 61: 393-397.
24. Tsiavou A, Hatziagelaki E, Chaidaroglou A, Manginas A, Koniavitou K, et al. (2004) TNF-alpha, TGF-beta1, IL-10, IL-6, gene polymorphisms in latent autoimmune diabetes of adults (LADA) and type 2 diabetes mellitus. J Clin Immunol 24: 591-599.
25. Vendrell J, Fernandez-Real JM, Gutierrez C, Zamora A, Simon I, et al. (2003) A polymorphism in the promoter of the tumor necrosis factor-alpha gene (-308) is associated with coronary heart disease in type 2 diabetic patients. Atherosclerosis 167: 257-264.
26. Zeggini E, Groves CJ, Parkinson JR, Halford S, Owen KR, et al. (2005) Large-scale studies of the association between variation at the TNF/LTA locus and susceptibility to type 2 diabetes. Diabetologia 48: 2013-2017.
27. Bouhaha R, Baroudi T, Ennafaa H, Vaillant E, Abid H, et al. (2010) Study of TNFalpha -308G/A and IL6 -174G/C polymorphisms in type 2 diabetes and obesity risk in the Tunisian population. Clin Biochem 43: 549-552.
28. Nishimura M, Obayashi H, Mizuta I, Hara H, Adachi T, et al. (2003) TNF, TNF receptor type 1, and allograft inflammatory factor-1 gene polymorphisms in Japanese patients with type 1 diabetes. Hum Immunol 64: 302-309.
29. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW, (1997) Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci U S A 94: 3195-3199.
30. Lee SC, Pu YB, Thomas GN, Lee ZS, Tomlinson B, et al. (2000) Tumor necrosis factor alpha gene G-308A polymorphism in the metabolic syndrome. Metabolism 49: 1021-1024.
31. Hoffstedt J, Eriksson P, Hellstrom L, Rossner S, Ryden M, et al. (2000) Excessive fat accumulation is associated with the TNF alpha-308 G/A promoter polymorphism in women but not in men. Diabetologia 43: 117-120.
32. Herrmann SM, Ricard S, Nicaud V, Mallet C, Arveiler D, et al. (1998) Polymorphisms of the tumour necrosis factor-alpha gene, coronary heart disease and obesity. Eur J Clin Invest 28: 59-66.
33. Brand E, Schorr U, Kunz I, Kertmen E, Ringel J, et al. (2001) Tumor necrosis factor-alpha-308 G/A polymorphism in obese Caucasians. Int J Obes Relat Metab Disord 25: 581-585.
34. Dalziel B, Gosby AK, Richman RM, Bryson JM, Caterson ID, (2002) Association of the TNF-alpha -308 G/A promoter polymorphism with insulin resistance in obesity. Obes Res 10: 401-407.
35. Yoon KH, Lee JH, Kim JW, Cho JH, Choi YH, et al. (2006) Epidemic obesity and type 2 diabetes in Asia. Lancet 368: 1681-1688.
36. Aminkeng F, Van Autreve JE, Koeleman BP, Quartier E, Van Schravendijk C, et al. (2007) TNFa microsatellite polymorphism modulates the risk of type 1 diabetes in the Belgian population, independent of HLA-DQ. Hum Immunol 68: 690-697.
37. Sookoian SC, Gonzalez C, Pirola CJ, (2005) Meta-analysis on the G-308A tumor necrosis factor alpha gene variant and phenotypes associated with the metabolic syndrome. Obes Res 13: 2122-2131.